---
title: "ESBER HENRY JEMIL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/49cd6036-dbf5-5eae-becf-9d70e785e29a
json: https://whiteintel.dev/api/public/dossier/49cd6036-dbf5-5eae-becf-9d70e785e29a
identifier: sec:0001391501
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ESBER HENRY JEMIL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001391501`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/49cd6036-dbf5-5eae-becf-9d70e785e29a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/49cd6036-dbf5-5eae-becf-9d70e785e29a  

## Ownership & control

### Holdings / subsidiaries

- **INNOVUS PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/dd12304d-86aa-525e-abde-ebc3028d9f4b
- **AVANYX THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/85839920-5280-5e41-aa6c-f50a51dd4a4a
- **APRICUS BIOSCIENCES, INC.** (director) — https://whiteintel.dev/entity/e7763fb4-4afc-5a47-a077-fda08793cb68
- **APRICUS BIOSCIENCES, INC.** (officer) — https://whiteintel.dev/entity/e7763fb4-4afc-5a47-a077-fda08793cb68
- **GALECTIN THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/f8080f77-4e50-5fe6-9c7b-cf0486465d72

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ESBER HENRY JEMIL**. Human view: https://whiteintel.dev/entity/49cd6036-dbf5-5eae-becf-9d70e785e29a · Structured JSON: https://whiteintel.dev/api/public/dossier/49cd6036-dbf5-5eae-becf-9d70e785e29a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._